This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Narita, M.
Right arrow Articles by Sakiyama, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Narita, M.
Right arrow Articles by Sakiyama, Y.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, September 2001, p. 1028-1030, Vol. 8, No. 5
1071-412X/01/$04.00+0   DOI: 10.1128/CDLI.8.5.1028-1030.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Significant Role of Interleukin-8 in Pathogenesis of Pulmonary Disease Due to Mycoplasma pneumoniae Infection

Mitsuo Narita,1,* Hiroshi Tanaka,2 Satoshi Yamada,3 Shosaku Abe,2 Tadashi Ariga,4 and Yukio Sakiyama4

Department of Pediatrics, Sapporo Tetsudo (JR) Hospital, Chuo-ku, Sapporo 060-0033,1 Third Department of Internal Medicine, Sapporo Medical University School of Medicine, Chuo-ku, Sapporo 060-8556,2 Department of Pediatrics, Health Sciences University of Hokkaido, Kita-ku, Sapporo 002-8072,3 and Department of Gene Therapy, Hokkaido University School of Medicine, Kita-ku, Sapporo 060-8638,4 Japan

Received 26 March 2001/Returned for modification 23 May 2001/Accepted 18 June 2001

We found elevated levels of interleukin-8 in pleural fluid samples from patients with pleural effusion and with a sustained fibrotic change of the lung due to Mycoplasma pneumoniae infection. This result suggests a critical role of interleukin-8 in the pathogenesis of a certain type of pulmonary disease caused by M. pneumoniae.

* Corresponding author. Mailing address: Department of Pediatrics, Sapporo Tetsudo (JR) Hospital, N 3 E 1 Chuo-ku, Sapporo 060-0033, Japan. Phone: 81-11-241-4971. Fax: 81-11-222-9260. E-mail: naritamy{at}d5.dion.ne.jp.

Clinical and Diagnostic Laboratory Immunology, September 2001, p. 1028-1030, Vol. 8, No. 5
1071-412X/01/$04.00+0   DOI: 10.1128/CDLI.8.5.1028-1030.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Matsuoka, M., Narita, M., Okazaki, N., Ohya, H., Yamazaki, T., Ouchi, K., Suzuki, I., Andoh, T., Kenri, T., Sasaki, Y., Horino, A., Shintani, M., Arakawa, Y., Sasaki, T. (2004). Characterization and Molecular Analysis of Macrolide-Resistant Mycoplasma pneumoniae Clinical Isolates Obtained in Japan. Antimicrob. Agents Chemother. 48: 4624-4630 [Abstract] [Full Text]  
  • Waites, K. B., Talkington, D. F. (2004). Mycoplasma pneumoniae and Its Role as a Human Pathogen. Clin. Microbiol. Rev. 17: 697-728 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»